CCAAT/enhancer-binding proteins modulate human T cell leukemia virus type 1 long terminal repeat activation

Virology

Volumn 348, Issue 2, 2006, Pages 354-369

  Grant, Christian ^a,c   Nonnemacher, Michael ^a,c   Jain, Pooja ^c   Pandya, Devanshi ^c   Irish, Bryan ^c   Williams, Simon C ^b   Wigdahl, Brian ^c  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

^c Center for Cancer Biology   (United States)

Author keywords

CCAAT enhancer binding protein; HAM TSP; HTLV 1; Long terminal repeat; Monocyte macrophage; Tax

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 4; CCAAT ENHANCER BINDING PROTEIN; CCAAT ENHANCER BINDING PROTEIN ALPHA; CCAAT ENHANCER BINDING PROTEIN BETA; CCAAT ENHANCER BINDING PROTEIN DELTA; CCAAT ENHANCER BINDING PROTEIN EPSILON; HETERODIMER; LEUCINE ZIPPER PROTEIN; TAX PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ACCESSORY CELL; ARTICLE; CELL LINEAGE; CONTROLLED STUDY; DIMERIZATION; DNA RESPONSIVE ELEMENT; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; LONG TERMINAL REPEAT; MACROPHAGE; MODULATION; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; TARGET CELL; TRANSACTIVATION; VIRUS PATHOGENESIS;

BASE SEQUENCE; BINDING, COMPETITIVE; CCAAT-ENHANCER-BINDING PROTEINS; DIMERIZATION; DNA, VIRAL; GENE EXPRESSION REGULATION, VIRAL; GENE PRODUCTS, TAX; GENES, PX; GENES, REPORTER; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; JURKAT CELLS; MODELS, BIOLOGICAL; P300-CBP TRANSCRIPTION FACTORS; PROTEIN STRUCTURE, QUATERNARY; TERMINAL REPEAT SEQUENCES; TRANS-ACTIVATION (GENETICS); TRANSFECTION; U937 CELLS;

HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 33646243209     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2005.12.024     Document Type: Article

References (84)

1. Banchereau J., and Steinman R.M. Dendritic cells and the control of immunity. Nature 392 6673 (1998) 245-252
2. Barnhart M.K., Connor L.M., and Marriott S.J. Function of the human T-cell leukemia virus type 1 21-base-pair repeats in basal transcription. J. Virol. 71 1 (1997) 337-344
3. Blobel G.A. CREB-binding protein and p300: molecular integrators of hematopoietic transcription. Blood 95 (2000) 745-755
4. Bosselut R., Duvall J.F., Gegonne A., Bailly M., Hemar A., Brady J., and Ghysdael J. The product of the c-ets-1 proto-oncogene and the related Ets2 protein act as transcriptional activators of the long terminal repeat of human T cell leukemia virus HTLV-1. EMBO J. 9 10 (1990) 3137-3144
5. Bosselut R., Lim F., Romond P.C., Frampton J., Brady J., and Ghysdael J. Myb protein binds to multiple sites in the human T cell lymphotropic virus type 1 long terminal repeat and transactivates LTR-mediated expression. Virology 186 2 (1992) 764-769
6. Colgin M.A., and Nyborg J.K. The human T-cell leukemia virus type 1 oncoprotein Tax inhibits the transcriptional activity of c-Myb through competition for the CREB binding protein. J. Virol. 72 11 (1998) 9396-9399
7. Crowe S., Zhu T., and Muller W.A. The contribution of monocyte infection and trafficking to viral persistence, and maintenance of the viral reservoir in HIV infection. J. Leukocyte Biol. 74 (2003) 635-641
8. Dan S., Tanimura A., and Yoshida M. Interaction of Gli-2 with CREB protein on DNA elements in the long terminal repeat of human T-cell leukemia virus type 1 is responsible for transcriptional activation by Tax protein. J. Virol. 73 (1999) 3258-3263
9. Descombes P., and Schibler U. A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA. Cell 67 (1991) 569-579
10. Farr A., and Roman A. A pitfall of using a second plasmid to determine transfection efficiency. Nucleic Acids Res. 20 (1991) 920
11. Franklin A.A., Kubik M.F., Uittenbogaard M.N., Brauweiler A., Utaisincharoen P., Matthews M.A., Dynan W.S., Hoeffler J.P., and Nyborg J.K. Transactivation by the human T-cell leukemia virus Tax protein is mediated through enhanced binding of activating transcription factor-2 (ATF-2) ATF-2 response and cAMP element-binding protein (CREB). J. Biol. Chem. 268 28 (1993) 21225-21231
12. Fujisawa J., Seiki M., Sato M., and Yoshida M. A transcriptional enhancer sequence of HTLV-I is responsible for trans-activation mediated by p40x of HTLV-I. EMBO J. 5 (1986) 713-718
13. Gachon F., Peleraux A., Thebault S., Dick J., Lemasson I., Devaux C., and Mesnard J.M. CREB-2, a cellular CRE-dependent transcription repressor, functions in association with Tax as an activator of the human T-cell leukemia virus type 1 promoter. J. Virol. 72 10 (1998) 8332-8337
14. Gachon F., Thebault S., Peleraux A., Devaux C., and Mesnard J.M. Molecular interactions involved in the transactivation of the human T-cell leukemia virus type 1 promoter mediated by Tax and CREB-2 (ATF-4). Mol. Cell. Biol. 20 (2000) 3470-3481
15. Gachon F., Gaudray G., Thebault S., Basbous J., Koffi J.A., Devaux C., and Mesnard J.M. The cAMP response element binding protein-2 (CREB-2) can interact with the C/EBP-homologous protein (CHOP). FEBS Lett. 502 (2001) 57-62
16. Gessain A., Barin F., Vernant J.C., Gout O., Maurs L., Calender A., and de The G. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 2 (1985) 407-410
17. Goren I., Tavor E., and Honigman A. Gene regulation mediated by interaction between HTLV-1 promoter elements and transcription factors Tax and CREB. Virology 256 2 (1999) 303-312
18. Grant C., Barmak K., Alefantis T., Yao J., Jacobson S., and Wigdahl B. Human T cell leukemia virus type I and neurologic disease: events in bone marrow, peripheral blood, and central nervous system during normal immune surveillance and neuroinflammation. J. Cell. Physiol. 190 (2002) 133-159
19. Henderson A.J., and Calame K.L. CCAAT/enhancer binding protein (C/EBP) sites are required for HIV-1 replication in primary macrophages but not CD4+ T cells. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 8714-8719
20. Hivin P., Gaudray G., Devaux C., and Mesnard J.M. Interaction between C/EBP beta and Tax down-regulates human T-cell leukemia virus type I transcription. Virology 318 (2004) 556-565
21. Kashanchi F., Duvall J.F., Dittmer J., Mireskandari A., Reid R.L., Gitlin S.D., and Brady J.N. Involvement of transcription factor YB-1 in human T-cell lymphotropic virus type I basal gene expression. J. Virol. 68 1 (1994) 561-565
22. Kim J., Cantwell C.A., Johnson P.F., Pfarr C.M., and Williams S.C. Transcriptional activity of CCAAT/enhancer-binding proteins is controlled by a conserved inhibitory doamin that is a target for sumoylation. J. Biol. Chem. 277 (2002) 38037-38044
23. Kimzey A.L., and Dynan W.S. Specific regions of contact between human T-cell leukemia virus type I Tax protein and DNA identified by photocross-linking. J. Biol. Chem. 273 22 (1998) 13768-13775
24. Kovacs K.A., Steinmann M., Magistretti P.J., Halfon O., and Cardinaux J.R. CCAAT/enhancer-binding protein family members recruit the coactivator CREB-binding protein and trigger its phosphorylation. J. Biol. Chem. 278 38 (2003) 36959-36965
25. Koyanagi Y., Itoyama Y., Nakamura N., Takamatsu K., Kira J., Iwamasa T., Goto I., and Yamamoto N. In vivo infection of human T-cell leukemia virus type I in non-T cells. Virology 196 1 (1993) 25-33
26. Kubota R., Umehara F., Izumo S., Ijichi S., Matsumuro K., Yashiki S., Fujiyoshi T., Sonoda S., and Osame M. HTLV-I proviral DNA amount correlates with infiltrating CD4+ lymphocytes in the spinal cord from patients with HTLV-I-associated myelopathy. J. Neuroimmunol. 53 1 (1994) 23-29
27. Kubota S., Mukudai Y., Hattori T., Eguchi T., Kondo S., and Takigawa M. Cell-type-specific trans-activation of herpes simplex virus thymidine kinase promoter by the human T-cell leukemia virus type I Tax protein. DNA Cell Biol. 20 (2001) 563-568
28. Laurance M.E., Kwok R.P., Huang M.S., Richards J.P., Lundblad J.R., and Goodman R.H. Differential activation of viral and cellular promoters by human T-cell lymphotropic virus-1 Tax and cAMP-responsive element modulator isoforms. J. Biol. Chem. 272 (1997) 2646-2651
29. Lee E.S., Sarma D., Zhou H., and Henderson A.J. CCAAT/enhancer binding proteins are not required for HIV-1 entry but regulate proviral transcription by recruiting coactivators to the long-terminal repeat in monocytic cells. Virology 299 (2002) 20-31
30. Lehky T.J., Fox C.H., Koenig S., Levin M.C., Flerlage N., Izumo S., Sato E., Raine C.S., Osame M., and Jacobson S. Detection of human T-lymphotropic virus type I (HTLV-I) tax RNA in the central nervous system of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by in situ hybridization. Ann. Neurol. 37 2 (1995) 167-175
31. Lekstrom-Himes J., and Xanthopoulos K.G. Biological role of the CCAAT/enhancer-binding protein family of transcription factors. J. Biol. Chem. 273 (1998) 28545-28548
32. Lemasson I., Polakowski N.J., Laybourn P.J., and Nyborg J.K. Transcription factor binding and histone modifications on the integrated proviral promoter in human T-cell leukemia virus-I-infected T-cells. J. Biol. Chem. 277 51 (2002) 49459-49465
33. Lenzmeier B.A., Giebler H.A., and Nyborg J.K. Human T-cell leukemia virus type 1 Tax requires direct access to DNA for recruitment of CREB binding protein to the viral promoter. Mol. Cell. Biol. 18 2 (1998) 721-731
34. Livengood J.A., and Nyborg J.K. The high-affinity Sp1 binding site in the HTLV-1 promoter contributes to Tax-independent basal expression. Nucleic Acids Res. 32 9 (2004) 2829-2837
35. Li-Weber M., Giaisi M., and Krammer P.H. Roles of CCAAT/enhancer-binding protein in transcriptional regulation of the human IL-5 gene. Eur. J. Immunol. 31 12 (2001) 3694-3703
36. Li-Weber M., Giaisi M., Chlichlia K., Khazaie K., and Krammer P.H. Human T cell leukemia virus type I Tax enhances IL-4 gene expression in T cells. Eur. J. Immunol. 31 9 (2001) 2623-2632
37. Lopez-Rodriguez C., Botella L., and Corbi A.L. CCAAT-enhancer-binding proteins (C/EBP) regulate the tissue specific activity of the CD11c integrin gene promoter through functional interactions with Sp1 proteins. J. Biol. Chem. 272 (1997) 29120-29126
38. Lu H., Pise-Masison C.A., Fletcher T.M., Schiltz R.L., Nagaich A.K., Radonovich M., Hager G., Cole P.A., and Brady J.N. Acetylation of nucleosomal histones by p300 facilitates transcription from Tax-responsive human T-cell leukemia virus type 1 chromatin template. Mol. Cell. Biol. 22 13 (2002) 4450-4462
39. Manns A., Miley W.J., Wilks R.J., Morgan O.S., Hanchard B., Wharfe G., Cranston B., Maloney E., Welles S.L., Blattner W.A., and Waters D. Quantitative proviral DNA and antibody levels in the natural history of HTLV-I infection. J. Infect. Dis. 180 5 (1999) 1487-1493
40. Marriott S.J., Lindholm P.F., Brown K.M., Gitlin S.D., Duvall J.F., Radonovich M.F., and Brady J.N. A 36-kilodalton cellular transcription factor mediates an indirect interaction of human T-cell leukemia/lymphoma virus type I TAX1 with a responsive element in the viral long terminal repeat. Mol. Cell. Biol. 10 8 (1990) 4192-4201
41. Mink S., Haenig B., and Klempnauer K.H. Interaction and functional collaboration of p300 and C/EBP beta. Mol. Cell. Biol. 17 11 (1997) 6609-6617
42. Muchardt C., Seeler J.S., Nirula A., Gong S., and Gaynor R. Transcription factor AP-2 activates gene expression of HTLV-I. EMBO J. 11 7 (1992) 2573-2581
43. Nagai M., Usuku K., Matsumoto W., Kodama D., Takenouchi N., Moritoyo T., Hashiguchi S., Ichinose M., Bangham C.R., Izumo S., and Osame M. Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. J. Neurovirol. 4 6 (1998) 586-593
44. Nagai M., Brennan M.B., Sakai J.A., Mora C.A., and Jacobson S. CD8+ T cells are an in vivo reservoir for human T-cell lymphotropic virus type I. Blood 98 (2001) 1858-1861
45. Nagulapalli S., Pongubala J.M.R., and Atchison M.L. Multiple proteins physically interact with PU.1: transcriptional synergy with NF-IL6beta (C/EBPdelta, CRP3). J. Immunol. 155 (1995) 4330-4338
46. Natsuka S., Akira S., Nishio Y., Hashimoto S., Sugita T., Isshiki H., and Kishimoto T. Macrophage differentiation-specific expression of NF-IL6, a transcription factor for interleukin-6. Blood 79 (1992) 460-466
47. Newbound G.C., Andrews J.M., O'Rourke J.P., Brady J.N., and Lairmore M.D. Human T-cell lymphotropic virus type 1 Tax mediates enhanced transcription in CD4+ T lymphocytes. J. Virol. 70 4 (1996) 2101-2106
48. Newman J.R.S., and Keating A.E. Comprehensive identification of human bZIP interactions with coiled-coil arrays. Science 300 (2003) 2097-2101
49. Nyborg J.K., and Dynan W.S. Interaction of cellular proteins with the human T-cell leukemia virus type I transcriptional control region. Purification of cellular proteins that bind the 21-base pair repeat elements. J. Biol. Chem. 265 14 (1990) 8230-8236
50. Nyborg J.K., Dynan W.S., Chen I.S., and Wachsman W. Binding of host-cell factors to DNA sequences in the long terminal repeat of human T-cell leukemia virus type I: implications for viral gene expression. Proc. Natl. Acad. Sci. U.S.A. 85 5 (1988) 1457-1461
51. Osame M., Osuku K., and Izumo S. HTLV-I-associated myelopathy: a new clinical entity. Lancet 1 (1986) 1031-1032
52. Ossipow V., Descombes P., and Schibler U. CCAAT/enhancer-binding protein mRNA is translated into multiple proteins with different transcription activation potentials. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 8219-8223
53. Podust L.M., Krezel A.M., and Kim Y. Crystal structure of the CCAAT box/enhancer-binding protein beta activating transcription factor-4 basic leucine zipper heterodimer in the absence of DNA. J. Biol. Chem. 276 (2001) 505-513
54. Poiesz B.J., Ruscetti F.W., Gazdar A.F., Bunn P.A., Minna J.D., and Gallo R.C. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc. Natl. Acad. Sci. U.S.A. 77 12 (1980) 7415-7419
55. Quiterio S., Grant C., Hogan T.H., Krebs F.C., and Wigdahl B. C/EBP- and Tat-mediated activation of the HIV-1 LTR in CD34+ hematopoietic progenitor cells. Biomed. Pharmacother. 57 (2003) 49-56
56. Ramji D.P., and Foka P. CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem. J. 365 Pt. 3 (2002) 561-575
57. Randolph G.J., Beaulieu S., Lebecque S., Steinman R.M., and Muller W.A. Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking. Science 282 5388 (1998) 480-483
58. Rivera-Walsh I., Waterfield M., Xiao G., Fong A., and Sun S.C. NF-kappaB signaling pathway governs TRAIL gene expression and human T-cell leukemia virus-I Tax-induced T-cell death. J. Biol. Chem. 276 44 (2001) 40385-40388
59. Rohr O., Marban C., Aunis D., and Schaeffer E. Regulation of HIV-1 gene transcription: from lymphocytes to microglial cells. J. Leukocyte Biol. 74 (2003) 736-749
60. Santambrogio L., Belyanskaya S.L., Fischer F.R., Cipriani B., Brosnan C.F., Ricciardi-Castagnoli P., Stern L.J., Strominger J.L., and Riese R. Developmental plasticity of CNS microglia. Proc. Natl. Acad. Sci. U.S.A. 98 11 (2001) 6295-6300
61. Schwartz C., Catez P., Rohr O., Lecestre D., Aunis D., and Schaeffer E. Functional interactions between C/EBP, Sp1, and COUP-TF regulate human immunodeficiency virus type 1 gene transcription in human brain cells. J. Virol. 74 (2000) 65-73
62. Stein B., Cogswell P.C., and Baldwin Jr. A.S. Functional and physical associations between NF-kappa B and C/EBP family members: a Rel domain-bZIP interaction. Mol. Cell. Biol. 13 7 (1993) 3964-3974
63. Tabakin-Fix Y., Huleihel M., and Aboud M. Activation of simian virus 40 promoter by HTLV-I Tax protein: role of NF-kB and CBP. Biochem. Biophys. Res. Commun. 318 (2004) 1052-1056
64. Thavathiru E., and Das G.M. Activation of pRL-TK by 12S E1A oncoprotein: drawbacks of using an internal reference reporter in transcriptional assays. BioTechniques 31 (2001) 528-532
65. Tillmann M., Wessner R., and Wigdahl B. Identification of human T-cell lymphotropic virus type I 21-base-pair repeat-specific and glial cell-specific DNA-protein complexes. J. Virol. 68 7 (1994) 4597-4608
66. Tsukada J., Misago M., Serino Y., Ogawa R., Murakami S., Nakanishi M., Tonai S., Kominato Y., Morimoto I., Auron P.E., and Eto S. Human T-cell leukemia virus type I Tax transactivates the promoter of human prointerleukin-1beta gene through association with two transcription factors, nuclear factor-interleukin-6 and Spi-1. Blood 90 8 (1997) 3142-3153
67. Valledor A.F., Borras F.E., Cullell-Young M., and Celada A. Transcription factors that regulate monocyte/macrophage differentiation. J. Leukocyte Biol. 63 4 (1998) 405-417
68. Van Orden K., Yan J.P., Ulloa A., and Nyborg J.K. Binding of the human T-cell leukemia virus Tax protein to the coactivator CBP interferes with CBP-mediated transcriptional control. Oncogene 18 25 (1999) 3766-3772
69. Vo N., and Goodman R.H. CREB-binding protein and p300 in transcriptional regulation. J. Biol. Chem. 276 (2001) 13505-13508
70. Wagner S., and Green M.R. HTLV-I Tax protein stimulation of DNA binding of bZIP proteins by enhancing dimerization. Science 262 5132 (1993) 395-399
71. Wessner R., and Wigdahl B. AP-1 derived from mature monocytes and astrocytes preferentially interacts with the HTLV-I promoter central 21 bp repeat. Leukemia 11 Suppl. 3 (1997) 21-24
72. Wessner R., Tillmann-Bogush M., and Wigdahl B. Characterization of a glial cell-specific DNA-protein complex formed with the human T cell lymphotropic virus type I (HTLV-I) enhancer. J. Neurovirol. 1 1 (1995) 62-77
73. Wessner R., Yao J., and Wigdahl B. Sp family members preferentially interact with the promoter proximal repeat within the HTLV-I enhancer. Leukemia 11 Suppl. 3 (1997) 10-13
74. Wigdahl B., and Brady J. Molecular aspects of HTLV-I: relationship to neurological diseases. J. Neurovirol. 2 (1996) 307-322
75. Williams S.C., Angerer N.D., and Johnson P.F. C/EBP proteins contain nuclear localization signals imbedded in their basic regions. Gene Expr. 6 6 (1997) 371-385
76. Williams S.C., Du Y., Schwartz R.C., Weiler S.R., Ortiz M., Keller J.R., and Johnson P.F. C/EBPepsilon is a myeloid-specific activator of cytokine, chemokine, and macrophage-colony-stimulating factor receptor genes. J. Biol. Chem. 273 22 (1998) 13493-13501
77. Yamano Y., Nagai M., Brennan M., Mora C.A., Soldan S.S., Tomaru U., Takenouchi N., Izumo S., Osame M., and Jacobson S. Correlation of human T-cell lymphotropic virus type 1 (HTLV-1) mRNA with proviral DNA load, virus-specific CD8+ T cells, and disease severity in HTLV-I-associated myelopathy (HAM/TSP). Blood 99 1 (2001) 88-94
78. Yan J.P., Garrus J.E., Giebler H.A., Stargell L.A., and Nyborg J.K. Molecular interactions between the coactivator CBP and the human T-cell leukemia virus Tax protein. J. Mol. Biol. 281 3 (1998) 395-400
79. Yao J., and Wigdahl B. Human T cell lymphotropic virus type I genomic expression and impact on intracellular signaling pathways during neurodegenerative disease and leukemia. Front. Biosci. 5 (2000) D138-D168
80. Yin M.J., Paulssen E., Seeler J., and Gaynor R. Chimeric proteins composed of Jun and CREB define domains required for interaction with the human T-cell leukemia virus type 1 Tax protein. J. Virol. 69 (1995) 6209-6218
81. Yin M.J., Paulssen E.J., Seeler J.S., and Gaynor R.B. Protein domains involved in both in vivo and in vitro interactions between human T-cell leukemia virus type I tax and CREB. J. Virol. 69 6 (1995) 3420-3432
82. Yoshida M., Miyoshi I., and Hinuma Y. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc. Natl. Acad. Sci. U.S.A. 79 6 (1982) 2031-2035
83. Zhang W., Nisbet J.W., Albrecht B., Ding W., Kashanchi F., Bartoe J.T., and Lairmore M.D. Human T-lymphotropic virus type 1 p30 (II) regulates gene transcription by binding CREB binding protein/p300. J. Virol. 75 (2001) 9885-9895
84. Zhao L.J., and Giam C.Z. Human T-cell lymphotropic virus type I (HTLV-I) transcriptional activator, Tax, enhances CREB binding to HTLV-I 21-base-pair repeats by protein-protein interaction. Proc. Natl. Acad. Sci. U.S.A. 89 15 (1992) 7070-7074